CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 7006 | 8278 | 84.6% | |
| CKD 4 | 2008 | 7941 | 9453 | 84.0% | |
| CKD 5 | 2009 | 1009 | 1115 | 90.5% | |
| CKD 5 | 2010 | 776 | 856 | 90.7% | |
| CKD 5 | 2011 | 791 | 883 | 89.6% | |
| CKD 5 | 2012 | 797 | 874 | 91.2% | |
| CKD 5 | 2013 | 763 | 851 | 89.7% | |
| CKD003 | 2014 | 688 | 753 | 91.4% | |
| CKD003 | 2015 | 646 | 701 | 92.2% | |
| CKD003 | 2016 | 617 | 669 | 92.2% |
